NO20063461L - Nye polysubstituert 1,1-pyridyloksycyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents
Nye polysubstituert 1,1-pyridyloksycyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende demInfo
- Publication number
- NO20063461L NO20063461L NO20063461A NO20063461A NO20063461L NO 20063461 L NO20063461 L NO 20063461L NO 20063461 A NO20063461 A NO 20063461A NO 20063461 A NO20063461 A NO 20063461A NO 20063461 L NO20063461 L NO 20063461L
- Authority
- NO
- Norway
- Prior art keywords
- pyridyloxycyclopropanamine
- compounds
- preparation
- methods
- pharmaceutical compositions
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004952 trihaloalkoxy group Chemical group 0.000 abstract 1
- 125000004385 trihaloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0508033A FR2889187B1 (fr) | 2005-07-28 | 2005-07-28 | Nouveaux composes 1,1-pyridinyloxycyclopropanamines polysusbstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063461L true NO20063461L (no) | 2007-01-29 |
Family
ID=35841768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063461A NO20063461L (no) | 2005-07-28 | 2006-07-27 | Nye polysubstituert 1,1-pyridyloksycyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7348344B2 (pl) |
| EP (1) | EP1748043B1 (pl) |
| JP (1) | JP2007077135A (pl) |
| KR (1) | KR100824830B1 (pl) |
| CN (1) | CN100519531C (pl) |
| AR (1) | AR054875A1 (pl) |
| AT (1) | ATE405550T1 (pl) |
| AU (1) | AU2006203241A1 (pl) |
| BR (1) | BRPI0603064A (pl) |
| CA (1) | CA2552827A1 (pl) |
| DE (1) | DE602006002328D1 (pl) |
| DK (1) | DK1748043T3 (pl) |
| EA (1) | EA011126B1 (pl) |
| ES (1) | ES2313589T3 (pl) |
| FR (1) | FR2889187B1 (pl) |
| GE (1) | GEP20084548B (pl) |
| HR (1) | HRP20080536T5 (pl) |
| MA (1) | MA28426B1 (pl) |
| MX (1) | MXPA06008415A (pl) |
| NO (1) | NO20063461L (pl) |
| NZ (1) | NZ548747A (pl) |
| PL (1) | PL1748043T3 (pl) |
| PT (1) | PT1748043E (pl) |
| SG (1) | SG129411A1 (pl) |
| SI (1) | SI1748043T1 (pl) |
| WO (1) | WO2007012762A1 (pl) |
| ZA (1) | ZA200606277B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2896800B1 (fr) * | 2006-01-30 | 2008-04-11 | Servier Lab | Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| PT2513085T (pt) * | 2009-11-18 | 2016-11-14 | Suven Life Sciences Ltd | Compostos bicíclicos como ligantes do recetor da acetilcolina nicotínico alfa4beta2 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2095350C1 (ru) * | 1993-10-13 | 1997-11-10 | Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) | 3-(n,n-диметилкарбамоилокси)-2-этил-6-метилпиридина сукцинат, обладающий антигипоксической активностью |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| FR2810664B1 (fr) * | 2000-06-27 | 2004-12-24 | Adir | Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2005
- 2005-07-28 FR FR0508033A patent/FR2889187B1/fr not_active Expired - Fee Related
-
2006
- 2006-07-10 MA MA29177A patent/MA28426B1/fr unknown
- 2006-07-20 CA CA002552827A patent/CA2552827A1/fr not_active Abandoned
- 2006-07-21 SG SG200604914A patent/SG129411A1/en unknown
- 2006-07-26 NZ NZ548747A patent/NZ548747A/en unknown
- 2006-07-26 US US11/493,070 patent/US7348344B2/en not_active Expired - Fee Related
- 2006-07-26 MX MXPA06008415A patent/MXPA06008415A/es active IP Right Grant
- 2006-07-27 DK DK06291219T patent/DK1748043T3/da active
- 2006-07-27 AR ARP060103249A patent/AR054875A1/es unknown
- 2006-07-27 PT PT06291219T patent/PT1748043E/pt unknown
- 2006-07-27 GE GEAP20069543A patent/GEP20084548B/en unknown
- 2006-07-27 KR KR1020060070569A patent/KR100824830B1/ko not_active Expired - Fee Related
- 2006-07-27 DE DE602006002328T patent/DE602006002328D1/de not_active Expired - Fee Related
- 2006-07-27 NO NO20063461A patent/NO20063461L/no not_active Application Discontinuation
- 2006-07-27 PL PL06291219T patent/PL1748043T3/pl unknown
- 2006-07-27 ES ES06291219T patent/ES2313589T3/es active Active
- 2006-07-27 SI SI200630083T patent/SI1748043T1/sl unknown
- 2006-07-27 AT AT06291219T patent/ATE405550T1/de not_active IP Right Cessation
- 2006-07-27 EP EP06291219A patent/EP1748043B1/fr active Active
- 2006-07-27 EA EA200601248A patent/EA011126B1/ru not_active IP Right Cessation
- 2006-07-27 WO PCT/FR2006/001832 patent/WO2007012762A1/fr not_active Ceased
- 2006-07-28 JP JP2006206041A patent/JP2007077135A/ja active Pending
- 2006-07-28 ZA ZA200606277A patent/ZA200606277B/xx unknown
- 2006-07-28 AU AU2006203241A patent/AU2006203241A1/en not_active Abandoned
- 2006-07-28 BR BRPI0603064-5A patent/BRPI0603064A/pt not_active IP Right Cessation
- 2006-07-28 CN CNB2006101089323A patent/CN100519531C/zh not_active Expired - Fee Related
-
2008
- 2008-11-19 HR HR20080536T patent/HRP20080536T5/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG129411A1 (en) | 2007-02-26 |
| AU2006203241A1 (en) | 2007-02-15 |
| KR20070015011A (ko) | 2007-02-01 |
| CN100519531C (zh) | 2009-07-29 |
| ZA200606277B (en) | 2007-04-25 |
| FR2889187A1 (fr) | 2007-02-02 |
| JP2007077135A (ja) | 2007-03-29 |
| WO2007012762A1 (fr) | 2007-02-01 |
| ATE405550T1 (de) | 2008-09-15 |
| MA28426B1 (fr) | 2007-02-01 |
| FR2889187B1 (fr) | 2007-09-07 |
| AR054875A1 (es) | 2007-07-25 |
| EA200601248A1 (ru) | 2007-04-27 |
| EA011126B1 (ru) | 2008-12-30 |
| CN1903843A (zh) | 2007-01-31 |
| MXPA06008415A (es) | 2007-01-29 |
| NZ548747A (en) | 2007-06-29 |
| HRP20080536T5 (en) | 2009-03-31 |
| SI1748043T1 (sl) | 2008-12-31 |
| PL1748043T3 (pl) | 2008-12-31 |
| EP1748043A1 (fr) | 2007-01-31 |
| US20070027191A1 (en) | 2007-02-01 |
| US7348344B2 (en) | 2008-03-25 |
| ES2313589T3 (es) | 2009-03-01 |
| GEP20084548B (en) | 2008-11-25 |
| EP1748043B1 (fr) | 2008-08-20 |
| HRP20080536T3 (en) | 2009-02-28 |
| CA2552827A1 (fr) | 2007-01-28 |
| PT1748043E (pt) | 2008-10-07 |
| BRPI0603064A (pt) | 2007-08-14 |
| KR100824830B1 (ko) | 2008-04-23 |
| DK1748043T3 (da) | 2008-12-08 |
| DE602006002328D1 (de) | 2008-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200500119A (es) | Derivados de tetraazabenzo [e] azuleno y sus analogos | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| CY1117324T1 (el) | Παραγωγα 1-φαινυλ-2-πυριδινυλ αλκυλ αλκοολων ως αναστολεις φωσφοδιεστερασης | |
| CY1120994T1 (el) | Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων | |
| NO20055590L (no) | Kinaseinhiberende fosfonatanaloger | |
| UA117800C2 (uk) | Похідні урацилу або тиміну для лікування гепатиту с | |
| CY1115893T1 (el) | Anti-μολυσματικες πυριμιδινες και χρησεις αυτων | |
| UY29886A1 (es) | Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones | |
| MX2010001754A (es) | Derivados de azepina como inhibidores de gamma secretasa. | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| CY1116339T1 (el) | Πολυμορφικες μορφες ενος μακροκυκλικου αναστολεα hcv | |
| NO20090835L (no) | Nye HIV-reverstranskriptaseinhibitorer | |
| PE20091425A1 (es) | Derivados de aminotiazol | |
| NO20085214L (no) | Nye pyridinanaloger | |
| NO20073287L (no) | 2,5 og 2,6-disubstituerte benzazol-analoger som proteinkinaseinhibitorer | |
| BRPI0413742B8 (pt) | composto antioxidante quimicamente estável, composição farmacêutica, método de redução do estresse oxidativo em uma célula in vitro e métodos de preparo e de síntese do referido composto antioxidante | |
| CY1113914T1 (el) | Νεα παραγωγα διυδροϊνδολονων, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις οι οποιες τα περιεχουν | |
| CY1109637T1 (el) | Νεα τρικυκλικα παραγωγα, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| MX2009006750A (es) | Derivados de azaadamantano espirociclicos y metodos de uso. | |
| ECSP066317A (es) | Compuestos | |
| NO20080079L (no) | AMPA-reseptorpotensiatorer | |
| DE602004023926D1 (de) | Selektive spirocyclische glucocorticoid-rezeptor-modulatoren | |
| NO20061981L (no) | Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist | |
| EA200901030A1 (ru) | Антагонист хроменового рецептора s1p1 | |
| NO20063461L (no) | Nye polysubstituert 1,1-pyridyloksycyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |